Medovex has entered into an international distribution agreement with Innosurge, a supplier of orthopaedic surgery equipment. The agreement covers the distribution of its DenerveXSystem throughout Scandinavia, including Denmark, Sweden, Norway and Finland.
Innosurge is expected to provide sales, marketing and distribution services for the launch of the DenerveX System.
The company’s patented DenerveX System, currently in final development and not yet commercially available, is designed to provide longer lasting relief of pain associated with the facet joint. According to a company release, studies indicate that 31% of lower back pain can be attributed to facet joint pain.
The DenerveX System consists of the DenerveX device, a single use device, and the DenerveX Pro-40 power generator. The DenerveX system is designed to provide a minimally invasive treatment option which combines two actions into one device.
DenerveX is not yet CE marked or cleared by the US Food and Drug Administration, and is not yet commercially available.